Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 13
2015 44
2016 59
2017 63
2018 77
2019 81
2020 153
2021 236
2022 140
2023 65
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

868 results

Results by year

Filters applied: . Clear all
Page 1
A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity.
Matsuda K, Migueles SA, Huang J, Bolkhovitinov L, Stuccio S, Griesman T, Pullano AA, Kang BH, Ishida E, Zimmerman M, Kashyap N, Martins KM, Stadlbauer D, Pederson J, Patamawenu A, Wright N, Shofner T, Evans S, Liang CJ, Candia J, Biancotto A, Fantoni G, Poole A, Smith J, Alexander J, Gurwith M, Krammer F, Connors M. Matsuda K, et al. J Clin Invest. 2021 Mar 1;131(5):e140794. doi: 10.1172/JCI140794. J Clin Invest. 2021. PMID: 33529172 Free PMC article. Clinical Trial.
Canine and Feline Influenza.
Wasik BR, Voorhees IEH, Parrish CR. Wasik BR, et al. Cold Spring Harb Perspect Med. 2021 Jan 4;11(1):a038562. doi: 10.1101/cshperspect.a038562. Cold Spring Harb Perspect Med. 2021. PMID: 31871238 Free PMC article. Review.
Influenza Reverse Genetics-Historical Perspective.
Neumann G. Neumann G. Cold Spring Harb Perspect Med. 2021 Apr 1;11(4):a038547. doi: 10.1101/cshperspect.a038547. Cold Spring Harb Perspect Med. 2021. PMID: 31964649 Free PMC article. Review.
SARS-CoV-2 Vaccines: Status Report.
Amanat F, Krammer F. Amanat F, et al. Immunity. 2020 Apr 14;52(4):583-589. doi: 10.1016/j.immuni.2020.03.007. Epub 2020 Apr 6. Immunity. 2020. PMID: 32259480 Free PMC article. Review.
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.
Scheaffer SM, Lee D, Whitener B, Ying B, Wu K, Liang CY, Jani H, Martin P, Amato NJ, Avena LE, Berrueta DM, Schmidt SD, O'Dell S, Nasir A, Chuang GY, Stewart-Jones G, Koup RA, Doria-Rose NA, Carfi A, Elbashir SM, Thackray LB, Edwards DK, Diamond MS. Scheaffer SM, et al. Nat Med. 2023 Jan;29(1):247-257. doi: 10.1038/s41591-022-02092-8. Epub 2022 Oct 20. Nat Med. 2023. PMID: 36265510
Nanotechnology Responses to COVID-19.
Ruiz-Hitzky E, Darder M, Wicklein B, Ruiz-Garcia C, Martín-Sampedro R, Del Real G, Aranda P. Ruiz-Hitzky E, et al. Adv Healthc Mater. 2020 Oct;9(19):e2000979. doi: 10.1002/adhm.202000979. Epub 2020 Sep 3. Adv Healthc Mater. 2020. PMID: 32885616 Review.
H9 Influenza Viruses: An Emerging Challenge.
Carnaccini S, Perez DR. Carnaccini S, et al. Cold Spring Harb Perspect Med. 2020 Jun 1;10(6):a038588. doi: 10.1101/cshperspect.a038588. Cold Spring Harb Perspect Med. 2020. PMID: 31871234 Free PMC article. Review.
Transmission routes of respiratory viruses among humans.
Kutter JS, Spronken MI, Fraaij PL, Fouchier RA, Herfst S. Kutter JS, et al. Curr Opin Virol. 2018 Feb;28:142-151. doi: 10.1016/j.coviro.2018.01.001. Epub 2018 Jan 17. Curr Opin Virol. 2018. PMID: 29452994 Free PMC article. Review.
868 results